Bio Green Med Solution, Inc. (ticker: BGMS) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of BGMS's SEC filings surfaces 4 active risk signals, including 3 late-filing signals, and 1 auditor-change signal. BGMS reported $0 in revenue and $3.00M for the period ending 2025-12-31, with operating cash flow of -$4.77M. Cash and equivalents stood at $3.50M (up 11.7% year-over-year). Total assets of $8.19M exceed total liabilities of $1.34M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
BGMS SEC Filings
Full cached SEC EDGAR filing history for BGMS, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.